Dr. Bynon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6431 Fannin St
Houston, TX 77030Phone+1 713-500-7400Fax+1 713-500-0785
Summary
- Dr. J. Steve Bynon is a general surgeon in Houston, TX and is affiliated with the McGovern School of Medicine University of Texas Houston. He received his medical degree from University of Tennessee Health Science Center College of Medicine and has been in practice 36 years. He specializes in hepatobiliary surgery, pancreas, and transplantation. He has 5 publications and over 50 citings.
Education & Training
- University of Nebraska Medical Center College of MedicineResidency, Surgery, 1991 - 1993
- University of Alabama Medical CenterResidency, Surgery, 1985 - 1990
- University of Tennessee Health Science Center College of MedicineClass of 1985
Certifications & Licensure
- TX State Medical License 2011 - 2026
- AL State Medical License 1987 - 2025
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- 2019 Honoree Houston Chapter ALF American Liver Foundation, 2019
Clinical Trials
- Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation Start of enrollment: 2008 Apr 01
Publications & Presentations
PubMed
- Blood Management in a Liver Transplant Recipient with Kidd (Jka) and Rhesus (D) Antibodies: A Case Report.Dakota D Butler, David A Hundley, Ha Y Lin, Vincenzo Villani, John S Bynon
A&A Practice. 2024-04-01 - 4 citationsSeroprevalence of Measles, Mumps, Rubella, and Varicella-Zoster Virus and Seroresponse to the Vaccinations in Adult Solid Organ Transplant Candidates.Hana Javaid, Pooja Prasad, Aleksandra De Golovine, Rodrigo Hasbun, Soma Jyothula
Transplantation. 2023-10-01 - 13 citationsCD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer.Erika Y Faraoni, Kanchan Singh, Vidhi Chandra, Olivereen Le Roux, Yulin Dai
Cancer Research. 2023-04-04
Professional Memberships
- Member
- Americian Society Transplant SurgeonsMember
- AASLDMember
- AHPBAMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: